104 related articles for article (PubMed ID: 7201814)
21. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
Zuidema J; Verhoeven J; Merkus FW
Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics of parenteral dexketoprofen trometamol in healthy subjects.
Valles J; Artigas R; Crea A; Muller F; Paredes I; Zapata A; Capriati A
Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():7-12. PubMed ID: 16801987
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
Danielson BG; Salmonson T; Derendorf H; Geisser P
Arzneimittelforschung; 1996 Jun; 46(6):615-21. PubMed ID: 8767353
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of intravenous camazepam in dogs.
Legheand J; Cuisinaud G; Bernard N; Riotte M; Sassard J
Arzneimittelforschung; 1982; 32(7):752-6. PubMed ID: 6127087
[TBL] [Abstract][Full Text] [Related]
26. High-performance liquid chromatographic determination and pharmacokinetic study of vitexin-2''-O-rhamnoside in rat plasma after intravenous administration.
Ying X; Gao S; Zhu W; Bi Y; Qin F; Li X; Li F
J Pharm Biomed Anal; 2007 Jul; 44(3):802-6. PubMed ID: 17459645
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetics of nalmefene after a single or multiple intravenous doses in Chinese healthy volunteers].
Liao RF; Zeng ZP; Wen YG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1816-9. PubMed ID: 18971181
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
29. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers.
Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001
[TBL] [Abstract][Full Text] [Related]
30. A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits.
Hu OY; Wu CY; Chan WK; Wu FY; Whang-Peng J
Biopharm Drug Dispos; 1996 Aug; 17(6):493-9. PubMed ID: 8866040
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of phenprocoumon.
Haustein KO; Hüller G
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):192-7. PubMed ID: 8032579
[TBL] [Abstract][Full Text] [Related]
32. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of CPU0213, a novel endothelin receptor antagonist, after intravenous administration in mice.
Guan L; Feng Y; Ji M; Dai DZ
Acta Pharmacol Sin; 2006 Mar; 27(3):367-71. PubMed ID: 16490175
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and bioequivalence testing of generic ondansetron preparations in healthy Thai male volunteers.
Rojanasthien N; Manorot M; Kumsorn B
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):548-54. PubMed ID: 10584976
[TBL] [Abstract][Full Text] [Related]
36. Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Ji HJ; Zhou XH; Zhu YB; Fan HW; Xiao DW; Hu Q
Pharmazie; 2008 Aug; 63(8):568-70. PubMed ID: 18771003
[TBL] [Abstract][Full Text] [Related]
37. [Azapropazone plasma levels under simultaneous treatment with an antacid or laxative].
Faust-Tinnefeldt G; Geissler HE; Mutschler E
Arzneimittelforschung; 1977; 27(12):2411-4. PubMed ID: 580058
[TBL] [Abstract][Full Text] [Related]
38. [Human pharmacokinetics of theophylline and etofylline from different formulations of a cardiotonic (author's transl)].
Erking W; Lücker PW; Niebch G; Thiemer K; Wetzelsberger K
Arzneimittelforschung; 1981; 31(2):371-9. PubMed ID: 7194656
[TBL] [Abstract][Full Text] [Related]
39. The pharmacology and pharmacokinetics of azapropazone - a review.
Jones CJ
Curr Med Res Opin; 1976; 4(1):3-16. PubMed ID: 770078
[TBL] [Abstract][Full Text] [Related]
40. Disposition of azapropazone in chronic renal and hepatic failure.
Breuing KH; Gilfrich HJ; Meinertz T; Wiegand UW; Jähnchen E
Eur J Clin Pharmacol; 1981; 20(2):147-55. PubMed ID: 7262176
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
